Recent Blog Posts

View Post: Aterovax's sPLA2 Activity Test Significantly Improves Prediction ...
17 Nov 2009 by Business Wire  
PARIS--(BUSINESS WIRE)-- Aterovax SA, a company developing innovative products for atherosclerosis, today announced data demonstrating that its blood test for secretory phospholipa. ... The PEACE trial is a randomized, multi-center study of trandolapril vs placebo in 8290 patients with stable coronary artery disease (CAD). sPLA2 activity levels identified individuals at increased risk of cardiovascular death (CVD) and the combination of CVD, myocardial infarction (MI) or ...
View Blog: Your Story - http://www.your-story.org/

---

View Post: Aterovax's SPLA2 Activity Test Significantly Improves Prediction ...
13 Nov 2009 by admin  
Aterovax SA, a company developing innovative products for atherosclerosis, today announced data demonstrating that its blood test for secretory phospholipase. ... The PEACE trial is a randomized, multi-center study of trandolapril vs placebo in 8290 patients with stable coronary artery disease (CAD). sPLA2 activity levels identified individuals at increased risk of cardiovascular death (CVD) and the combination of CVD, myocardial infarction (MI) or stroke during 5 years ...
View Blog: Fitness Master - http://fitness-master.info/

---

View Post: {beta}-Adrenergic Antagonists in Hypertension: A Review of the ...
25 Nov 2009 by Warmack, T S., Estes, M. A, Heldenbrand,...  
The MAPHY (Metoprolol Atherosclerosis Prevention in Hypertensives) trial14 and the study conducted by Yurenev et al.15 reported benefits with β-blockers. The MAPHY trial was an open-label trial comparing the effects of metoprolol with those of ... The INVEST (International Verapamil-Trandolapril Study) compared the effects of verapamil sustained-release (SR) with those of atenolol using a PROBE study design.19 At the end of the trial, most patients were taking combination ...
View Blog: Annals of Pharmacotherapy current issue - http://www.theannals.com/

---

View Post: Effects of Olmesartan, an Angiotensin II Receptor Blocker, and ...
18 Nov 2009
CONCLUSIONS: In subjects with type 2 diabetes and hypertension but with normoalbuminuria, the use of trandolapril plus ... [Similar reduction in new cases of type 2 diabetes with angiotensin receptor blo. Rev Med Liege Jul 22, 2005 ... diabetic patients has been shown to accelerate the progression of atherosclerosis and angiotensin II type-I (AT1) receptor blocker (ARB ... . Methods and Results Type 2 diabetic patients with hypertension received either ARB (candesartan), ...
View Blog: Recent Ion Channel Publications compiled... - http://www.ionchannels.org/

---

View Post: does it matter how hypertension is controlled?
30 Dec 2008 by Robert Hawkins  
these agents have been shown to inhibit atherosclerosis in various animal models with hypercholesterolemia and to improve endothelium-dependent vasodilatation in isolated arteries and in patients with vascular disease.12,13 diuretics do ...
View Blog: Health News: Interesting and Relevant - http://interestinghealthnews.blogspot.com/

---

View Post: Hypertension and Diabetes
10 Oct 2005
In a study using trandolapril, Weir and colleagues showed that systolic blood pressure decreased similarly in African-American patients and in white patients but at higher doses in the former group (4 mg vs 1 mg). Therefore, when proper doses are ... Abstract; Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke. ...
View Blog: Medscape Cardiology Headlines - http://www.medscape.com/cardiologyhome

---

View Post: statins en af en ace-remmers
1 Dec 2007 by roodbont  
leukocyte adhesion to the endothelium occurs early on in atherosclerosis and is mediated by the release of cytokines. statins have been found to selectively inhibit leukocyte-function antigen (lfa)-1 and intercellular adhesion molecule ...
View Blog: Archief Roodbont - http://archiefroodbont.blogspot.com/

---

View Post: medication treatment of hypertension-which drug are best
14 Jun 2008 by kesihatan lelaki dan wanita  
the international verapamil trandolapril study (invest), which compared the calcium channel blocker verapamil to the beta blocker atenolol in 22576 patients (pepine et al 2003). the swedish trial in old patients with hypertension 2 ...
View Blog: health-mental-prosperity - http://health-mental-prosperity.blogspot.com/

---

View Post: USPharmacist.com > Pharmacologic Management of Post-Acute Coronary ...
20 Feb 2007
Trials involving ramipril, trandolapril, captopril, and lisinopril therapy have shown improved survival and reduced morbidity among patients who have had an MI with left ventricular dysfunction. The Heart Outcomes Prevention Evaluation ( HOPE) .... AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol. 2006;47:2130-2139. ...
View Blog: Untitled - http://www.uspharmacist.com/home/

---

View Post: Cardiovascular High-Risk Patients -- Treat to Protect, But Whom ...
26 Mar 2008
Sex related cardiovascular risk stratification based on quantification of atherosclerosis and inflammation. Atherosclerosis. 2007 March 25; [Epub ahead of print]. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating ... A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1995;333:1670-1676. Abstract; The SOLVD Investigators. ...
View Blog: Medscape Public Health & Prevention Headlines - http://www.medscape.com/publichealth

---